Tennessee Oncology / Sarah Cannon Research Institute — Nashville, Tennessee

Tennessee Oncology / Sarah Cannon Research Institute is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Tennessee Oncology / Sarah Cannon Research Institute has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.

Sponsors: AbbVie, Astellas Pharma Global Development, Inc., Leap Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology / Sarah Cannon Research Institute?

Tennessee Oncology / Sarah Cannon Research Institute has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology / Sarah Cannon Research Institute conducted?

Tennessee Oncology / Sarah Cannon Research Institute has 5 clinical trials on record, with 1 currently active. Their work covers Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.

Is Tennessee Oncology / Sarah Cannon Research Institute accredited by Crixeo Health?

Yes — Tennessee Oncology / Sarah Cannon Research Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Tennessee Oncology / Sarah Cannon Research Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.